Physician profile
James D Davis
NPI 1003898685
$24,753.55
in general payments reported to CMS, 2019-2025
7 companies · $5,758 in 2025
The $5,758 reported for 2025 was more than what 94% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $395 · 2020: $3,220 · 2021: $3,500 · 2022: $3,852 · 2023: $5,066 · 2024: $2,964 · 2025: $5,758.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $14K · Food and Beverage: $35.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $13,751.63 |
| Food and Beverage | $35.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $13,751.63 | 2023-2025 | Colink Mini, Colink Plating System |
| In2bones USA, LLC | $9,616.96 | 2019-2022 | |
| Trilliant Surgical LLC. | $1,215.62 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $112.16 | 2019 | |
| Djo, LLC | $21.74 | 2022 | |
| Amgen INC. | $21.63 | 2024 | Krystexxa |
| Heron Therapeutics, INC. | $13.81 | 2025 | Aponvie |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.